1 |
Pillaiyar, T., Manickam, M. and Jung, S. H. 2017. Recent development of signaling pathways inhibitors of melanogenesis. Cell Signal. 40, 99-115.
DOI
|
2 |
Pillaiyar, T., Namasivayam, V., Manickam, M. and Jung, S. H. 2018. Inhibitors of Melanogenesis: An Updated Review. J. Med. Chem. 61, 7395-7418.
DOI
|
3 |
Schiaffino, M. V. 2010. Signaling pathways in melanosome biogenesis and pathology. Int. J. Biochem. Cell Biol. 42, 1094-1104.
DOI
|
4 |
Solano, F., Briganti, S., Picardo, M. and Ghanem, G. 2006. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res. 19, 550-571.
DOI
|
5 |
Videira, I. F., Moura, D. F. and Magina, S. 2013. Mechanisms regulating melanogenesis. An. Bras. Dermatol. 88, 76-83.
DOI
|
6 |
Wolf Horrell, E. M., Boulanger, M. C. and D'Orazio, J. A. 2016. Melanocortin 1 receptor: structure, function, and regulation. Front Genet. 7, 95.
|
7 |
Bonaventure, J., Domingues, M. J. and Larue, L. 2013. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 26, 316-325.
DOI
|
8 |
Costin, G. E. and Hearing, V. J. 2007. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 21, 976-94.
DOI
|
9 |
D'Mello, S. A., Finlay, G. J. and Baguley, B. C. and Askarian-Amiri, M. E. 2016. Signaling pathways in melanogenesis. Int. J. Mol. Sci. 17, 1144.
DOI
|
10 |
Davis, E. C. and Callender, V. D. 2010. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J. Clin. Aesthet. Dermatol. 3, 20-31.
|
11 |
ElObeid, A. S., Kamal-Eldin, A., Abdelhalim, M. A. K. and Haseeb, A. M. 2017. Pharmacological Properties of Melanin and its Function in Health. Basic Clin. Pharmacol. Toxicol. 120, 515-522.
DOI
|
12 |
Gunia-Krzyzak, A., Popiol, J. and Marona, H. 2016. Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds. Curr. Med. Chem. 23, 3548-3574.
DOI
|
13 |
Hearing, V. J. 2011. Determination of melanin synthetic pathways. J. Invest Dermatol. 131, E8-E11.
DOI
|
14 |
Ito, S., Wakamatsu, K. 2008. Chemistry of mixed melanogenesis - pivotal roles of dopaquinone. Photochem. Photobiol. 84, 582-592.
DOI
|
15 |
Lin, J. Y. and Fisher, D. E. 2007. Melanocyte biology and skin pigmentation. Nature 445, 843-850.
DOI
|
16 |
Niu, C. and Aisa, H. A. 2017. Upregulation of melanogenesis and tyrosinase activity: potential agents for vitiligo. Molecules 22, E1303.
DOI
|
17 |
Park, H. Y., Kosmadaki, M., Yaar, M. and Gilchrest, B.A. 2009. Cellular mechanisms regulating human melanogenesis. Cell Mol. Life Sci. 66, 1493-1506.
DOI
|